Moving the Needle on Prescription Drug Costs: Using the Innovation Center and Other Demonstration Authority

This brief examines how the CMS Innovation Center (also known as CMMI) and Section 402 demonstration authority could become pathways for the Biden Administration to implement policy changes related to prescription drug costs.

Read the full post on Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation